Plaintiffs lawyers are seeking multicounty litigation status in New Jersey courts for claims stemming from the use of Stryker LFIT Anatomic Cobalt Chromium V40 Femoral Head devices made by Stryker Orthopedics. The application, which was made public on Wednesday, follows a bid concerning the V40 on Jan. 13 for federal multidistrict litigation status at the Judicial Panel on Multidistrict Litigation.
The V40 has been the subject of a voluntary recall announced by the Food and Drug Administration, and users have experienced wearing away of the device where it connects to the femoral stem, Ellen Relkin of Weitz & Luxenberg said in a letter to Administrative Director of the Courts Glenn Grant. Users experience a release of metal particles into surrounding tissue and bone, putting them at risk for the necrosis of tissue and bone cells, as well as elevated levels of cobalt and chromium in the blood, and necessitating revision surgery, Relkin stated. The defect puts users at risk of loss of mobility, pain, joint dislocation and broken bones, Relkin said.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
